Different bile acids have different regulatory effects on the activity of the NLRP3 inflammatory body (Guan et al. 2022), which suggests that the change of bile acid profiles may affect the activity of NLRP3 inflammatory bodies, and then affect the progress of HBV-related HCC. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.